Stock & Company Details
ADARx Pharmaceuticals $ADRX
Price:
N/A
N/A
N/A
$1.9B
52 Week High:
N/A
10 Day Average Volume:
N/A
N/A
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
N/A
ADRX technical indicators
Latest ADARx Pharmaceuticals (ADRX) indicator readings as of 2026-10-08.
Overview
Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.
Signal:
Volatility: N/A
Sentiment:
Finance Bot
🤖
Ask your questions
Start by typing a question below.
